Phase 1 Trial for Prolanta in Advanced Ovarian Cancer Recruiting for Second Dose Group
News
Oncolix has started enrolling patients for the second dosing group in a Phase 1 trial of Prolanta for the treatment of advanced ovarian cancer. In the first dose group, Prolanta ... Read more